Status:
COMPLETED
A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne
Lead Sponsor:
Allergan
Conditions:
Acne Vulgaris
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
A study comparing the topical application of Aczone® plus Differin® versus Duac® plus Differin® in patients with severe facial acne (facial acne vulgaris).
Eligibility Criteria
Inclusion
- Severe facial acne (acne vulgaris)
Exclusion
- History of significant anemia or hemolysis
- History of enteritis (eg, regional enteritis, ulcerative colitis, pseudomembranous colitis, antibiotic-associated colitis)
- History of lupus, rosacea, or seborrheic dermatitis
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
286 Patients enrolled
Trial Details
Trial ID
NCT01231334
Start Date
August 1 2010
End Date
June 1 2011
Last Update
July 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miramar, Florida, United States